Variability in Baseline Liver Test Values in Clinical Trials: Challenges in Enhancing Drug-Induced Liver Injury Assessment in Subjects with Liver Disease-Reference-Cited by-同舟云学术

Variability in Baseline Liver Test Values in Clinical Trials: Challenges in Enhancing Drug-Induced Liver Injury Assessment in Subjects with Liver Disease

Published:2018 Issue: Volume: Page:431-457
ISSN:1557-2153
Container-title:Methods in Pharmacology and Toxicology
language:
Short-container-title:

Author:

Tesfaldet Bereket,Csako Gyorgy,Patel Tejas,Shamsuzzaman Md,Almario Eileen Navarro

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-7677-5_21

Reference81 articles.

1. Ioannou GN, Boyko EJ, Lee SP (2006) The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 101(1):76–82. https://doi.org/10.1111/j.1572-0241.2005.00341.x

2. Liu Z, Que S, Xu J, Peng T (2014) Alanine aminotransferase-old biomarker and new concept: a review. Int J Med Sci 11(9):925–935. https://doi.org/10.7150/ijms.8951

3. Bell BP, Manos MM, Zaman A, Terrault N, Thomas A, Navarro VJ, Dhotre KB, Murphy RC, Van Ness GR, Stabach N, Robert ME, Bower WA, Bialek SR, Sofair AN (2008) The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol 103(11):2727–2736.; quiz 2737. https://doi.org/10.1111/j.1572-0241.2008.02071.x

4. Pan WC, Wu CD, Chen MJ, Huang YT, Chen CJ, Su HJ, Yang HI (2016) Fine particle pollution, alanine transaminase, and liver cancer: a Taiwanese prospective cohort study (REVEAL-HBV). J Natl Cancer Inst 108(3). https://doi.org/10.1093/jnci/djv341

5. Fischbein A (1985) Liver function tests in workers with occupational exposure to polychlorinated biphenyls (PCBs): comparison with yusho and yu-cheng. Environ Health Perspect 60:145–150

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STUDY TO KNOW INCIDENCE OF DRUG INDUCED HEPATITIS IN PATIENTS USING ANTI- TUBERCULOSIS DRUGS AND REVEALING ITS RISK FACTORS;INDO AM J PHARM SCI;2019

2. RISK FACTORS AND DEMOGRAPHIC CHARACTERISTICS FOR HEPATITIS DUE TO MEDICATION IN PATIENTS OF TB;INDO AM J PHARM SCI;2019

3. STUDY TO KNOW INCIDENCE OF DRUG INDUCED HEPATITIS IN PATIENTS USING ANTI- TUBERCULOSIS DRUGS AND ITS RISK FACTORS;INDO AM J PHARM SCI;2018